Pau Sancho-Bru and his team lead the study that links CXCR4 with the process of dedifferentiation of hepatocytes and tissue damage.
The period for submitting applications for the fellowship, which will last two years, from 2024 to 2026, is now open. Francesc Valldeoriola, a neurol1
Led by researchers from IDIBAPS-Hospital Clínic Barcelona, the study shows that the technique can be a safe and effective alternative for complex cas1
The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Study1
They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the Lym1
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
One of the projects is coordinated by Glòria Garrabou, the head of the group Hereditary metabolic diseases and muscular diseases, and the other by Os1
This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.
Four visits were organised this year: two devoted to a research project on mantle cell lymphoma; and two to a project aimed at preventing intravenous1
